Skip to content

To evaluate the incidence of shivering, analgesic quality and post-operative complications of cesarean section, treated with sputum sufentanil and tramadol

To evaluate the incidence of shivering, analgesic quality and post-operative complications of cesarean section, treated with sputum sufentanil and tramadol

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20151228025732N25
Enrollment
135
Registered
2017-12-20
Start date
2017-03-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complications after cesarean section. Maternal care for scar from previous cesarean delivery

Interventions

Intervention 1: Intervention group 1: Spinal anesthesia with 2.5 cc Bupivacaine 0.5%. Intervention 2: Intervention group 2: Spinal anesthesia with 2.5 cc bupivacaine 0.5% and 10 mg tramadol. Intervent
Treatment - Other
Intervention group 1: Spinal anesthesia with 2.5 cc Bupivacaine 0.5%
Intervention group 2: Spinal anesthesia with 2.5 cc bupivacaine 0.5% and 10 mg tramadol.
Intervention group 3: Spinal anesthesia with 2.5 cc of bupivacaine 0.5% and 10-5 micrograms (equivalent to 1-2 cc) of sufentanil.

Sponsors

Semnan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: No Contraindication of Spinal Anesthesia No history of sensitivity to the three drugs used in this study and other local anesthetics no neuropathy no previous history of non-gestational cesarean Women 18 to 40 years

Exclusion criteria

Exclusion criteria: women with GI disease preterm delivery febrile women (sub-axillary temperature greater than 37.5) preeclampsia obese women (BMI> 35) cesarean delivery more than 4 times receiving antiemetic drugs 24 hours before Surgery Patients with gestational hypertension Narcotic recipients during surgery Diabetic History of PONV Receiving misoprostol Patients who cannot perform medication

Design outcomes

Primary

MeasureTime frame
Pain relief time. Timepoint: Before and after anesthesia and after delivery (first 20 minutes, every 3 minutes and up to recovery, every 5 minutes), measurements are recorded and recorded. Method of measurement: Examination.;Chill. Timepoint: Before and after anesthesia and after delivery (first 20 minutes, every 3 minutes and up to recovery, every 5 minutes), measurements are recorded and recorded. Method of measurement: See.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElham saffarieh

Semnan University of Medical Sciences

are20935@gmail.com+98 23 3345 1336

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026